Pathophysiology and treatment of diabetic retinopathy. - Wikidata - awgldk - TriplyDB

Pathophysiology and treatment of diabetic retinopathy.

Pathophysiology and treatment of diabetic retinopathy.

http://www.wikidata.org/entity/Q34528134

about

Agent-based model of angiogenesis simulates capillary sprout initiation in multicellular networks.Zebrafish--on the move towards ophthalmological research The effect of lithospermic acid, an antioxidant, on development of diabetic retinopathy in spontaneously obese diabetic rats Danhong Huayu Koufuye Prevents Diabetic Retinopathy in Streptozotocin-Induced Diabetic Rats via Antioxidation and Anti-Inflammation.Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy Interruption of Wnt signaling in Müller cells ameliorates ischemia-induced retinal neovascularization.Comparative evaluation of combined navigated laser photocoagulation and intravitreal ranibizumab in the treatment of diabetic macular edema Diabetes and retinal vascular dysfunction.18F-FP-PEG2-β-Glu-RGD2: A Symmetric Integrin αvβ3-Targeting Radiotracer for Tumor PET Imaging.[Diabetic maculopathy].The vasodilating effects of insulin and lactate are increased in precapillary arterioles in the porcine retina ex vivo.Diabetic Retinopathy in Patients with Diabetic Nephropathy: Development and Progression.A study on the association of diabetic dermopathy with nephropathy and retinopathy in patients with type 2 diabetes mellitus.Association of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathy The diameter response of retinal arterioles in diabetic maculopathy is reduced during hypoxia and is unaffected by the inhibition of cyclo-oxygenase and nitric oxide synthesis.Ursodeoxycholic Acid Attenuates Endoplasmic Reticulum Stress-Related Retinal Pericyte Loss in Streptozotocin-Induced Diabetic Mice.Retinal oximetry in patients with ischaemic retinal diseases.Short-term cost analysis of complications related to glycated hemoglobin in patients with type 1 diabetes in the Italian setting.Sympathovagal balance and 1-h postload plasma glucose in normoglucose tolerant hypertensive patients.MicroRNA-126 inhibits cell viability and invasion in a diabetic retinopathy model via targeting IRS-1.Chronic hyperglycemia inhibits vasoregression in a transgenic model of retinal degeneration.High cystatin C levels predict severe retinopathy in type 2 diabetes patients.Agent-based computational model of retinal angiogenesis simulates microvascular network morphology as a function of pericyte coverage.Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy.Retinopathy in subjects with type 2 diabetes at a tertiary diabetes clinic in Durban, South Africa: Clinical, biochemical and genetic factors.Tang Wang Ming Mu Granule Attenuates Diabetic Retinopathy in Type 2 Diabetes Rats.N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors.The role of retinopathy distribution and other lesion types for the definition of examination intervals during screening for diabetic retinopathy.Diabetic Retinopathy in the Spontaneously Diabetic Torii Rat: Pathogenetic Mechanisms and Preventive Efficacy of Inhibiting the Urokinase-Type Plasminogen Activator Receptor System.Impact of intensive treatment on serum methylglyoxal levels among individuals with screen-detected type 2 diabetes: the ADDITION-Denmark study.Regularity of follow-up, glycemic burden, and risk of microvascular complications in patients with type 2 diabetes: a 9-year follow-up study.Acetagastrodin effects on retinal oscillatory potentials in patients during the early stages of diabetes.ILM peeling in nontractional diabetic macular edema: review and metanalysis.Homonoia riparia and its major component, myricitrin, inhibit high glucose-induced apoptosis of human retinal pericytes.Molecular mechanisms of extracellular vesicle-induced vessel destabilization in diabetic retinopathy.Paeoniflorin Suppressed High Glucose-Induced Retinal Microglia MMP-9 Expression and Inflammatory Response via Inhibition of TLR4/NF-κB Pathway Through Upregulation of SOCS3 in Diabetic Retinopathy.Assessment of Global and Local Alterations in Retinal Layer Thickness in Ins2 (Akita) Diabetic Mice by Spectral Domain Optical Coherence Tomography.

P2860

Q27334865-8C153722-E028-4016-B68B-AB05BEF73E56 Q30415226-2AF98763-4F11-40B3-A81E-1F78ED4BFFFB Q33721347-E5280D08-81F7-4DEA-B4CB-8FC6098D1278 Q33791268-A615FC3C-9B56-47D7-9833-D97132521538 Q34005734-2DCBDBBB-C3DC-4746-8B80-233E54F58FC4 Q34278108-18FACA25-ACD9-4F2A-9851-91E6D434887B Q34775904-5ACCE0E0-3304-4662-A597-3609512119A8 Q35017752-28436E8E-635E-4A6E-AB17-9B20857F1172 Q35784807-FD83E589-ABCD-4B01-823A-9201A74B8A38 Q35792895-4678D2F6-8FF2-4240-BA57-AB66A8F0D713 Q35968362-AAE70DFE-AAD2-4784-A700-013372556278 Q36114211-C5BA0513-2D61-4921-9827-41B7E877BA58 Q37444532-0462F6CB-A5B6-4303-9689-FD6A292F9EFB Q37569809-AD87302C-D59C-436A-B351-CDCA0D2E86D4 Q38391635-A3883AD9-354C-4E17-948C-5F42806F1DAA Q38719213-6B56D0E1-9CA8-47F9-A173-13E66476894C Q38944073-0E77C6F5-DDF5-4DAC-8BD9-7F3A1C881028 Q40973741-E600A361-4FE2-42CF-96EE-2466C1DC2DD5 Q41153540-E19F098B-6B00-458C-B4D2-85C9DFD2B183 Q41701922-B81DD1A6-CF8C-4207-9D52-A545EB845A58 Q43821945-7EC86529-B488-439A-8F20-6EA570D1240F Q44002468-CB0B5C09-4741-4115-BAD9-E954E65B1F6D Q45065026-375A8AFA-8556-4E9B-8A5B-D02216305E6B Q46433119-0523C6CD-B6ED-4421-8DCA-00BE21DD1447 Q47099578-5E4E4AB6-464C-463E-9F07-A637CDDEAE6B Q47194606-1C1C340A-1823-4BC1-A6C1-28E67796B338 Q47797389-BB30D8AD-5192-43C0-B5ED-D501D2521D39 Q48213384-33EDF272-4A33-43E3-8639-D15304C4A917 Q49724247-CC0257C6-E4E5-46F6-8630-87CD94F914A4 Q50565934-FF08E283-A636-4B63-9F2D-24DD5B2FEB74 Q51310478-B5AD16B6-8EB9-4BBF-9585-85C84673A452 Q51482536-3A46AB9B-8ADD-4BB0-89E5-0913CB209DCA Q51791449-0ABEAD63-FBC8-42E7-85A9-516173567500 Q52753708-3EEE37FE-D64F-419C-A8F2-0091FC4C8E76 Q53376431-33D2AC12-4E0F-4230-9B92-B84A71EC7FB1 Q54363541-AADDFC6A-8EFB-423F-B561-932D128584D9 Q55031356-AFEA053D-00F4-411E-9868-AFF26EB51D7A

P2860

Pathophysiology and treatment of diabetic retinopathy.

http://www.wikidata.org/entity/Q34528134

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Pathophysiology and treatment of diabetic retinopathy.

@ast

Pathophysiology and treatment of diabetic retinopathy.

@en

Pathophysiology and treatment of diabetic retinopathy.

@nl

type

label

Pathophysiology and treatment of diabetic retinopathy.

@ast

Pathophysiology and treatment of diabetic retinopathy.

@en

Pathophysiology and treatment of diabetic retinopathy.

@nl

prefLabel

Pathophysiology and treatment of diabetic retinopathy.

@ast

Pathophysiology and treatment of diabetic retinopathy.

@en

Pathophysiology and treatment of diabetic retinopathy.

@nl

P1433

Q34528134-9D991B93-B4D0-4160-ACB6-1FB90FB3AAD4

P1476

Q34528134-65310F1A-9F83-4B04-A551-93FC64E64353

P2093

Q34528134-1699B1B9-1DA4-4654-94DD-43D125BCE45E

Q34528134-7838FE91-8973-4A78-A6DC-320C0FF5F7BD

Q34528134-7C14705F-E61D-46C7-A82A-A30730F12645

P2860

Q34528134-00DABCFB-7786-4F24-99E2-3DAA805B8DF9

Q34528134-02338E2C-77CB-4985-98A5-B957D52380B2

Q34528134-04EBE80F-EA4A-4419-B928-76745D5AA59F

Q34528134-09FF0DE7-D25E-4A0C-AE80-19F2C4321443

Q34528134-0A13B4A8-9DA0-483D-BAA7-9EAB14875AFF

Q34528134-0BFBBB10-3A91-49D9-ADAE-BED9CB94FE1D

Q34528134-0C376248-2ACB-4DB8-8B33-A910FEFDF501

Q34528134-0E725A48-9CB8-4399-97A9-2BDFEB3385E9

Q34528134-0E89EEE9-EB11-47B7-8420-199B9ED16DE1

Q34528134-0FE83356-39EB-472F-A053-62E3E66F3123

P2888

Q34528134-5DB0ADB5-8B35-41A8-9175-370981C1DA93

P304

Q34528134-902CD053-6F00-4676-84F2-729596D40F2B

P31

Q34528134-01E50E25-D284-4E33-9D5F-258C60282132

P356

Q34528134-2ED7774C-00CB-47FD-8FA3-525A3EA30971

P433

Q34528134-A842F703-FF11-40C8-B84F-C883F6066A60

P478

Q34528134-C2DDDA44-3093-4CE1-B30B-D8058E085F08

P50

Q34528134-A250EC96-16A2-4B80-A0C9-86D3A68938DC

P577

Q34528134-41289D0C-F8E6-4A5F-9045-49DE07B81932

P6179

Q34528134-E7AF103E-2AB0-4037-B60D-035F0B9EFA5C

P698

Q34528134-34DB5A17-84B7-44F8-BF10-9A08EDADC2AA

P921

Q34528134-CE751C7B-A938-48CE-A3BB-F8BB8677BBEC

P356

S00592-012-0449-3

P1433

Acta Diabetologica

P1476

Pathophysiology and treatment of diabetic retinopathy.

@en

P2093

Claudia Del Turco

http://www.w3.org/2001/XMLSchema#string

Ilaria Zucchiatti

http://www.w3.org/2001/XMLSchema#string

Rosangela Lattanzio

http://www.w3.org/2001/XMLSchema#string

P2860

New approaches for the treatment of diabetic macular oedema: recommendations by an expert panel

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation

Glutamate-induced apoptosis in neuronal cells is mediated via caspase-dependent and independent mechanisms involving calpain and caspase-3 proteases as well as apoptosis inducing factor (AIF) and this process is inhibited by equine estrogens

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Initial experience with the Pascal photocoagulator: a pilot study of 75 procedures.

Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy.

Optical cross-sectional observation of resolved diabetic macular edema associated with vitreomacular separation.

Fibrovascular ingrowth and recurrent haemorrhage following diabetic vitrectomy.

P2888

s00592-012-0449-3

P304

1-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00592-012-0449-3

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

Francesco Bandello

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1008215122

http://www.w3.org/2001/XMLSchema#string

P698

23277338

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology